Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates

Show other versions (1)

Bibliographic Details
Main Author:	Hugh James Freeman
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-10-01
Series:	Clinical Medicine Insights: Gastroenterology
Online Access:	http://la-press.com/medical-management-of-ulcerative-colitis-with-a-specific-focus-on-5-am-a3386

Similar Items

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
by: Hugh James Freeman
Published: (2012-01-01)

Medication adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis
by: Moshkovska, Tetyana
Published: (2011)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
by: Jun Miyoshi, et al.
Published: (2018-10-01)

Efficacy of 5-Aminosalicylic Acid Enemas in the Treatment of Distal Ulcerative Colitis
by: MG Robinson, et al.
Published: (1990-01-01)

The Synergistic Effects of 5-Aminosalicylic Acid and Vorinostat in the Treatment of Ulcerative Colitis
by: Long He, et al.
Published: (2021-05-01)

Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
by: Tripathi K, et al.
Published: (2021-08-01)

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
by: Yan Yan, et al.
Published: (2019-12-01)

5-Aminosalicylic Acid Enemas in the Maintenance of Remission in Distal Ulcerative Colitis and Proctitis
by: Lloyd R Sutherland, et al.
Published: (1987-01-01)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
by: Jun Xu, et al.
Published: (2018-06-01)

USE OF 5-AMINOSALICYLIC ACID FOR TREATMENT OF ULCERATIVE COLITIS IN DIFFERENT DOSAGE MODES
by: M. V. Shapina, et al.
Published: (2017-11-01)

Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis.
by: Jin Lee, et al.
Published: (2019-01-01)

Prevention of Relapse in Ulcerative Colitis Using Oral or Topical 5-Aminosalicylic Acid Therapy
by: Lloyd R Sutherland
Published: (1993-01-01)

Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate
by: M Campieri, et al.
Published: (1990-01-01)

5-Aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: an updated meta-analysis.
by: Li-Na Zhao, et al.
Published: (2014-01-01)

Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids.
by: Juan Suárez, et al.
Published: (2012-01-01)

Therapeutic efficacy of the combination therapy of corticosteroids and 5-aminosalicylic acid for treatment of pyoderma gangrenosum with ulcerative colitis
by: Wei Chen, et al.
Published: (2020-01-01)

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
by: Shinta Mizuno, et al.
Published: (2020-01-01)

Ketotifen Treatment of Active Colitis in Patients with 5-Aminosalicylate Intolerance
by: John K Marshall, et al.
Published: (1998-01-01)

A New Chinese Medicine Intestine Formula Greatly Improves the Effect of Aminosalicylate on Ulcerative Colitis
by: Baohai Liu, et al.
Published: (2017-01-01)

Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study
by: Reidar Fossmark, et al.
Published: (2021-06-01)

Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase
by: Akira Madarame, et al.
Published: (2021-01-01)

Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase.
by: Akira Madarame, et al.
Published: (2021-01-01)

THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE
by: O. V. Knyazev, et al.
Published: (2018-01-01)

Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis.
by: Xin Zhao, et al.
Published: (2016-01-01)

A Double-Blind, Placebo Controlled, Multicentre Study of the Efficacy And Safety of 5-Aminosalicylic Acid Tablets in the Treatment of Ulcerative Colitis
by: LR Sutherland, et al.
Published: (1990-01-01)

Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta-analysis of randomized controlled trials
by: Yong Jiang, et al.
Published: (2016-03-01)

Antineoplastic Effects of 5-Aminosalicylates and Potential Cancer Preventive Role in Inflammatory Bowel Disease
by: Hugh J Freeman
Published: (2004-01-01)

Synthesis and evaluation of mutual azo prodrug of 5-aminosalicylic acid linked to 2-phenylbenzoxazole-2-yl-5-acetic acid in ulcerative colitis
by: Jilani JA, et al.
Published: (2013-07-01)

Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab
by: Freeman HJ
Published: (2013-11-01)

Gut Microbiome Changes in Patients with Active Left-sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy
by: Dagmar Schierová, et al.
Published: (2020-10-01)

Evolution of Collagenous Colitis into Severe and Extensive Ulcerative Colitis
by: Hugh J Freeman, et al.
Published: (2007-01-01)

The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry.
by: Tomohiro Fukuda, et al.
Published: (2017-01-01)

5-Aminosalicylic Acid Inhibits Acute Clostridium difficile Toxin A-Induced Colitis in Rats
by: Steven R. Vigna
Published: (2014-01-01)

Ulcerative Colitis in the Chinese Population of Vancouver, British Columbia
by: Hugh Chaun, et al.
Published: (1994-01-01)

Effect of acid-reducing agents on clinical relapse in ulcerative colitis with pH-dependent-released 5-aminosalicylic acid: a multicenter retrospective study in Japan
by: Yosuke Shimodaira, et al.
Published: (2021-04-01)

Aminosalicylates
by: Williams C
Published: (2001-01-01)

Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
by: Ajit Sood, et al.
Published: (2020-10-01)

Dysplasia Risk in Ileal Pouches after Reconstructive Surgery for Ulcerative Colitis
by: Hugh J Freeman
Published: (2001-01-01)

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
by: Armuzzi A, et al.
Published: (2013-04-01)

Pouchitis-Associated Iritis (Uveitis) Following Total Proctocolectomy and Ileal Pouch-to-Anal Anastomosis in Ulcerative Colitis
by: Hugh James Freeman
Published: (2001-01-01)